Summary of quantum dot IHC
| . | CD20 . | HLA-DR . | Blimp1 . |
|---|---|---|---|
| MHC II(+) DLBCL (n = 8) | |||
| Range | 110.0-185.0 | 95.0-160.0 | 0.0-45.0 |
| Median | 150.0 | 127.5 | 30.0 |
| Mean | 150.6 | 124.4 | 25.0 |
| MHC II-punctate DLBCL (n = 13) | |||
| Range | 50.0-275.0 | 0.0-140.0 | 0.0-70.0 |
| Median | 150.0 | 10.0 | 0.0 |
| Mean | 162.3 | 37.7 | 12.3 |
| MHC II(−) DLBCL (n = 7) | |||
| Range | 110.0-280.0 | 0.0-0.0 | 0.0-75.0 |
| Median | 180.0 | 0.0 | 0.0 |
| Mean | 179.3 | 0.0 | 18.6 |
| PBL (n = 13) | |||
| Range | 0.0-30.0 | 0.0-0.0 | 0.0-110.0 |
| Median | 0.0 | 0.0 | 75.0 |
| Mean | 2.0 | 0.0 | 25.0 |
| . | CD20 . | HLA-DR . | Blimp1 . |
|---|---|---|---|
| MHC II(+) DLBCL (n = 8) | |||
| Range | 110.0-185.0 | 95.0-160.0 | 0.0-45.0 |
| Median | 150.0 | 127.5 | 30.0 |
| Mean | 150.6 | 124.4 | 25.0 |
| MHC II-punctate DLBCL (n = 13) | |||
| Range | 50.0-275.0 | 0.0-140.0 | 0.0-70.0 |
| Median | 150.0 | 10.0 | 0.0 |
| Mean | 162.3 | 37.7 | 12.3 |
| MHC II(−) DLBCL (n = 7) | |||
| Range | 110.0-280.0 | 0.0-0.0 | 0.0-75.0 |
| Median | 180.0 | 0.0 | 0.0 |
| Mean | 179.3 | 0.0 | 18.6 |
| PBL (n = 13) | |||
| Range | 0.0-30.0 | 0.0-0.0 | 0.0-110.0 |
| Median | 0.0 | 0.0 | 75.0 |
| Mean | 2.0 | 0.0 | 25.0 |
Data are range and averages for CD20 (B-cell marker), HLA-DR (MHC II), and Blimp1 (plasma cell marker) in 28 cases of DLBCL divided by MHC II status, and 15 cases of PBL.